Anti-HMGA1 antibody [EPR16649]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal HMGA1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 3 publications.
View Alternative Names
HMGIY, HMGA1, High mobility group protein HMG-I/HMG-Y, HMG-I(Y), High mobility group AT-hook protein 1, High mobility group protein R, High mobility group protein A1
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-HMGA1 antibody [EPR16649] (AB202070)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized BxPC-3 (Human pancreas adenocarcinoma cells) cells labeling HMGA1 with ab202070 at 1/500 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green). Confocal image showing nuclear staining on BxPC-3 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows :
-ve control 1 : ab202070 at 1/500 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-HMGA1 antibody [EPR16649] (AB202070)
Intracellular flow cytometric analysis of 2% paraformaldehyde-fixed HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling HMGA1 with ab202070 at 1/150 dilution (red) compared with a rabbit monoclonal IgG isotype control (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/150 dilution was used as the secondary antibody.
- WB
Lab
Western blot - Anti-HMGA1 antibody [EPR16649] (AB202070)
Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM/TBST We recommend using 1% SDS Hot lysis prepare method to get desired Western Blot results.
Lanes 1 - 4:
Western blot - Anti-HMGA1 antibody [EPR16649] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/hmga1-antibody-epr16649-bsa-and-azide-free-ab251363'>ab251363</a>) at 1/10000 dilution
Lanes 1 - 4:
Western blot - Anti-HMGA1 antibody [EPR16649] (ab202070) at 1/10000 dilution
Lane 1:
HCT 116 (Human colorectal carcinoma epithelial cell) whole cell lysate prepared in RIPA lysis method at 20 µg
Lane 2:
HCT 116 (Human colorectal carcinoma epithelial cell) whole cell lysate prepared in 1% SDS Hot lysis method at 20 µg
Lane 3:
MDA-MB-231 (Human breast adenocarcinoma epithelial cell) whole cell lysate prepared in RIPA lysis method at 20 µg
Lane 4:
MDA-MB-231 (Human breast adenocarcinoma epithelial cell) whole cell lysate prepared in 1%SDS Hot lysis method at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
Observed band size: 17 kDa
false
Exposure time: 60s
- WB
Lab
Western blot - Anti-HMGA1 antibody [EPR16649] (AB202070)
Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM/TBST
Lanes 1 - 3:
Western blot - Anti-HMGA1 antibody [EPR16649] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/hmga1-antibody-epr16649-bsa-and-azide-free-ab251363'>ab251363</a>) at 1/10000 dilution
Lanes 1 - 3:
Western blot - Anti-HMGA1 antibody [EPR16649] (ab202070) at 1/10000 dilution
Lane 1:
MDA-MB-231 (Human breast adenocarcinoma epithelial cell) nuclear fraction lysate at 15 µg
Lane 2:
MDA-MB-231 (Human breast adenocarcinoma epithelial cell) cytoplasm fraction lysate at 15 µg
Lane 3:
MDA-MB-231 (Human breast adenocarcinoma epithelial cell) membrane fraction lysate at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
Observed band size: 17 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-HMGA1 antibody [EPR16649] (AB202070)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-HMGA1 antibody [EPR16649] (ab202070) at 1/10000 dilution
Lane 1:
NCCIT (Human pluripotent embryonal carcinoma) whole cell lysate at 10 µg
Lane 2:
BxPC-3 (Human pancreas adenocarcinoma cells) whole cell lysate at 10 µg
Lane 3:
HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 10 µg
Lane 4:
SK-OV-3 (Human ovarian cancer cell line) whole cell lysate at 10 µg
Lane 5:
Caco-2 (Human colorectal adenocarcinoma cells) whole cell lysate at 10 µg
Lane 6:
Human testis tissue lysate at 10 µg
Lane 7:
Human lung tissue lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 12 kDa
Observed band size: 18 kDa
false
Related conjugates and formulations (1)
-
Anti-HMGA1 antibody [EPR16649] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
PLoS neglected tropical diseases 19:e0013443 PubMed40892762
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 45: PubMed33649788
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 12:9915-9928 PubMed33116849
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com